J9144 is a valid 2023 HCPCS Code that could be used to indicate Injection, daratumumab, 10 mg and hyaluronidase-fihj for reimbursement purposes.
J9144 belongs to Medical Care Type of Service and has been in effect since Jan 01, 2021.
Daratumumab, hyaluronidase
J9144 code information
| HCPCS code: | J9144 |
| Description: | INJECTION, DARATUMUMAB, 10 MG AND HYALURONIDASE-FIHJ |
| Effective Date: | Jan 01, 2021 |
| Added Date: | Jan 01, 2021 |
| Termination Date: | HCPCS J9144 was terminated on Nov 30, -0001 |
| Pricing indicator: | 51 - DRUGS |
| Multi Pricing indicator: | A - NOT APPLICABLE AS HCPCS PRICED UNDER ONE METHODOLOGY |
| Coverage code: | C - CARRIER JUDGMENT |
| BETOS code: | O1D - CHEMOTHERAPY |
| Action code: | A - ADD PROCEDURE OR MODIFIER CODE |
| Type of Service: |
1 - MEDICAL CARE
|
| Anesthesia BUQ: | 0 |
Below a selection of HCPCS codes related to J9144